Paul Edward Walker - 15 May 2025 Form 4 Insider Report for Allakos Inc. (ALLK)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Issuer symbol
ALLK
Transactions as of
15 May 2025
Transactions value $
$0
Form type
4
Filing time
15 May 2025, 16:28:27 UTC
Previous filing
03 Oct 2024
Next filing
06 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Walker Paul Edward Director 2855 SAND HILL ROAD, MENLO PARK /s/ Zachary Bambach, attorney-in-fact 15 May 2025 0001553150

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLK Common Stock Disposed to Issuer -2,760,860 -100% 0 15 May 2025 See Note 2 F1, F2
transaction ALLK Common Stock Disposed to Issuer -3,386,400 -100% 0 15 May 2025 See Note 3 F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -37,600 -100% $0.000000 0 15 May 2025 Common Stock 37,600 $16.00 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -16,000 -100% $0.000000 0 15 May 2025 Common Stock 16,000 $40.00 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -7,700 -100% $0.000000 0 15 May 2025 Common Stock 7,700 $72.54 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -7,700 -100% $0.000000 0 15 May 2025 Common Stock 7,700 $99.83 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -99,590 -100% $0.000000 0 15 May 2025 Common Stock 99,590 $2.62 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -86,762 -100% $0.000000 0 15 May 2025 Common Stock 86,762 $4.81 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -41,000 -100% $0.000000 0 15 May 2025 Common Stock 41,000 $1.42 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Paul Edward Walker is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
F2 The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 16 securities in which the Reporting Person has no pecuniary interest.
F3 The Reporting Person is a manager of NEA 18 VGE GP, LLC, which is the sole general partner of NEA Partners 18 VGE, L.P. ("NEA Partners 18 VGE"). NEA Partners 18 VGE is the sole general partner of NEA 18 Venture Growth Equity, L.P. ("NEA 18 VGE"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 18 VGE in which the Reporting Person has no pecuniary interest.
F4 This option was cancelled without consideration pursuant to the terms of the Merger Agreement.